File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1167/iovs.66.4.63
- Scopus: eid_2-s2.0-105003760950
- PMID: 40261662
- WOS: WOS:001479551900005
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank
| Title | Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank |
|---|---|
| Authors | |
| Keywords | age-related macular diseases cardiovascular health Life’s Essential 8 |
| Issue Date | 22-Apr-2025 |
| Publisher | C.V. Mosby Co. |
| Citation | Investigative Ophthalmology & Visual Science, 2025, v. 66, n. 4 How to Cite? |
| Abstract | PURPOSE. This study aimed to investigate the correlation between cardiovascular health (CVH), evaluated through the Life’s Essential 8 (LE8) score, and the risk of new-onset age-related macular degeneration (AMD). METHODS. This longitudinal analysis included 271,274 participants who were free of both cardiovascular diseases and AMD at baseline. The LE8 score was classified into three categories: low (<50 points), moderate (50 to <80 points), and high (≥80 points), with higher scores indicating better CVH. Cox proportional hazards models were used to explore the relationships between the CVH and AMD incidence. Furthermore, the population attributable risk (PAR%) was calculated for CVH and each individual metric. RESULTS. During an average follow-up duration of 10.9 years, a total of 7468 (2.8%) cases of AMD were documented. Individuals with moderate and high CVH levels had a 14% (hazard ratio [HR] = 0.86; 95% confidence interval [CI], 0.78–0.94) and 23% (HR = 0.77; 95% CI, 0.69-0.86) reduced risk of developing AMD, respectively. A linear dose-response relationship was identified between the cumulative LE8 score and the incidence of AMD. Attaining optimal CVH in all individuals could potentially avert 9.4% (95% CI, 3.7%–15.1%) of AMD cases. Among the CVH metrics, ideal blood glucose and blood pressure levels were related to a reduction of 3.3% and 8.7% in AMD cases, respectively. CONCLUSIONS. Enhanced CVH is significantly associated with a reduced risk of developing AMD. Promoting CVH through the LE8 guideline might potentially contribute to the prevention of AMD. |
| Persistent Identifier | http://hdl.handle.net/10722/358000 |
| ISSN | 2023 Impact Factor: 5.0 2023 SCImago Journal Rankings: 1.422 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Peng, Yu | - |
| dc.contributor.author | Zhang, Yuzhou | - |
| dc.contributor.author | Kam, Ka Wai | - |
| dc.contributor.author | Wong, Gavin | - |
| dc.contributor.author | Ho, Mary | - |
| dc.contributor.author | Sezto, Simon | - |
| dc.contributor.author | Au, Sunny | - |
| dc.contributor.author | Zhang, Xiujuan | - |
| dc.contributor.author | Ng, Mandy P.H. | - |
| dc.contributor.author | Ip, Patrick | - |
| dc.contributor.author | Young, Alvin | - |
| dc.contributor.author | Pang, Chi Pui | - |
| dc.contributor.author | Tham, Clement C. | - |
| dc.contributor.author | Chen, Li Jia | - |
| dc.contributor.author | Yam, Jason C. | - |
| dc.date.accessioned | 2025-07-23T00:31:11Z | - |
| dc.date.available | 2025-07-23T00:31:11Z | - |
| dc.date.issued | 2025-04-22 | - |
| dc.identifier.citation | Investigative Ophthalmology & Visual Science, 2025, v. 66, n. 4 | - |
| dc.identifier.issn | 1552-5783 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/358000 | - |
| dc.description.abstract | <p>PURPOSE. This study aimed to investigate the correlation between cardiovascular health (CVH), evaluated through the Life’s Essential 8 (LE8) score, and the risk of new-onset age-related macular degeneration (AMD). METHODS. This longitudinal analysis included 271,274 participants who were free of both cardiovascular diseases and AMD at baseline. The LE8 score was classified into three categories: low (<50 points), moderate (50 to <80 points), and high (≥80 points), with higher scores indicating better CVH. Cox proportional hazards models were used to explore the relationships between the CVH and AMD incidence. Furthermore, the population attributable risk (PAR%) was calculated for CVH and each individual metric. RESULTS. During an average follow-up duration of 10.9 years, a total of 7468 (2.8%) cases of AMD were documented. Individuals with moderate and high CVH levels had a 14% (hazard ratio [HR] = 0.86; 95% confidence interval [CI], 0.78–0.94) and 23% (HR = 0.77; 95% CI, 0.69-0.86) reduced risk of developing AMD, respectively. A linear dose-response relationship was identified between the cumulative LE8 score and the incidence of AMD. Attaining optimal CVH in all individuals could potentially avert 9.4% (95% CI, 3.7%–15.1%) of AMD cases. Among the CVH metrics, ideal blood glucose and blood pressure levels were related to a reduction of 3.3% and 8.7% in AMD cases, respectively. CONCLUSIONS. Enhanced CVH is significantly associated with a reduced risk of developing AMD. Promoting CVH through the LE8 guideline might potentially contribute to the prevention of AMD.</p> | - |
| dc.language | eng | - |
| dc.publisher | C.V. Mosby Co. | - |
| dc.relation.ispartof | Investigative Ophthalmology & Visual Science | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | age-related macular diseases | - |
| dc.subject | cardiovascular health | - |
| dc.subject | Life’s Essential 8 | - |
| dc.title | Associations of Cardiovascular Health and New-Onset Age-Related Macular Diseases From UK Biobank | - |
| dc.type | Article | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1167/iovs.66.4.63 | - |
| dc.identifier.pmid | 40261662 | - |
| dc.identifier.scopus | eid_2-s2.0-105003760950 | - |
| dc.identifier.volume | 66 | - |
| dc.identifier.issue | 4 | - |
| dc.identifier.isi | WOS:001479551900005 | - |
| dc.identifier.issnl | 0146-0404 | - |
